KYC is one time exercise with a SEBI registered intermediary while dealing in securities markets (Broker/ DP/ Mutual Fund etc.). | No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.   |   Prevent unauthorized transactions in your account – Update your mobile numbers / email ids with your stock brokers. Receive information of your transactions directly from exchange on your mobile / email at the EOD | Filing Complaint on SCORES - QUICK & EASY a) Register on SCORES b) Mandatory details for filing complaints on SCORE - Name, PAN, Email, Address and Mob. no. c) Benefits - speedy redressal & Effective communication   |   BSE Prices delayed by 5 minutes...<< Prices as on Jun 15, 2026 - 3:06PM >>  ABB India 6766.1  [ 0.64% ]  ACC 1334.5  [ 2.30% ]  Ambuja Cements 423.2  [ 4.29% ]  Asian Paints 2746.5  [ 2.06% ]  Axis Bank 1355.55  [ 2.92% ]  Bajaj Auto 10062.55  [ -0.55% ]  Bank of Baroda 274.65  [ 2.73% ]  Bharti Airtel 1822.55  [ 2.27% ]  Bharat Heavy 378.75  [ 2.20% ]  Bharat Petroleum 302.2  [ 5.54% ]  Britannia Industries 5165.35  [ 1.09% ]  Cipla 1388.8  [ 0.42% ]  Coal India 443.7  [ -0.54% ]  Colgate Palm 2078.9  [ 2.47% ]  Dabur India 426.15  [ 0.94% ]  DLF 587.15  [ 4.24% ]  Dr. Reddy's Lab. 1273.9  [ -0.09% ]  GAIL (India) 170.35  [ 2.59% ]  Grasim Industries 3105.35  [ 0.52% ]  HCL Technologies 1109.2  [ -0.07% ]  HDFC Bank 772.4  [ 3.73% ]  Hero MotoCorp 4963.05  [ 2.63% ]  Hindustan Unilever 2167.55  [ 1.32% ]  Hindalco Industries 1021.4  [ -0.23% ]  ICICI Bank 1340.35  [ 1.74% ]  Indian Hotels Co. 679.85  [ 3.72% ]  IndusInd Bank 916.9  [ 3.03% ]  Infosys 1116.45  [ 0.22% ]  ITC 285.15  [ 1.01% ]  Jindal Steel 1148.5  [ 2.37% ]  Kotak Mahindra Bank 403.35  [ 2.61% ]  L&T 4050.2  [ 4.94% ]  Lupin 2292.7  [ 0.82% ]  Mahi. & Mahi 3043.35  [ 1.40% ]  Maruti Suzuki India 13371.25  [ 2.12% ]  MTNL 30.83  [ 7.99% ]  Nestle India 1375.85  [ -3.23% ]  NIIT 87.15  [ 2.25% ]  NMDC 90.89  [ 2.78% ]  NTPC 353.95  [ 0.55% ]  ONGC 246.15  [ -2.53% ]  Punj. NationlBak 106.85  [ 0.56% ]  Power Grid Corpn. 284.8  [ -0.65% ]  Reliance Industries 1292.75  [ 2.39% ]  SBI 1016.9  [ 1.62% ]  Vedanta 309.5  [ 1.46% ]  Shipping Corpn. 297  [ 3.77% ]  Sun Pharmaceutical 1807.25  [ 0.72% ]  Tata Chemicals 746.6  [ 0.76% ]  Tata Consumer 1100.15  [ -0.81% ]  Tata Motors Passenge 389.4  [ 3.62% ]  Tata Steel 197.85  [ -0.08% ]  Tata Power Co. 393.6  [ 0.86% ]  Tata Consult. Serv. 2161.5  [ 1.23% ]  Tech Mahindra 1429.4  [ -2.41% ]  UltraTech Cement 11107.95  [ 2.53% ]  United Spirits 1272.35  [ 1.13% ]  Wipro 180.1  [ 1.52% ]  Zee Entertainment 112.34  [ 0.74% ]  
  • Share Prices
  • Tools
  • News
  • Company Details
  • Financial Data
  • Results
  • Key Financial Ratios
  • Reports
  • Corporate Announcements
  • Equity History

    • Company Information

    Indian Indices
    • Loading....

    Global Indices
    • Loading....

    Forex
    • Loading....

    SYNGENE INTERNATIONAL LTD.

    15 June 2026 | 02:49

    Industry >> Pharmaceuticals

    Select Another Company

    ISIN No INE398R01022 BSE Code / NSE Code 539268 / SYNGENE Book Value (Rs.) 119.90 Face Value 10.00
    Bookclosure 26/06/2026 52Week High 729 EPS 7.85 P/E 57.90
    Market Cap. 18336.67 Cr. 52Week Low 380 P/BV / Div Yield (%) 3.79 / 0.28 Market Lot 1.00
    Security Type Other
    • Select another Company

    Quarterly Trends

    Syngene International Ltd. Aarey Drugs & Pharmaceuticals Ltd.
    Year Ends (Months) 202603(3) 202512(3) 202603(3) 202512(3)
    OprtIncome Syngene International Ltd. 960.00 834.40 Aarey Drugs & Pharmaceuticals Ltd. 189.47 96.43
    OtherRecurrInc Syngene International Ltd. 21.60 14.50 Aarey Drugs & Pharmaceuticals Ltd. -0.43 4.18
    Operating profit Syngene International Ltd. 189.00 87.60 Aarey Drugs & Pharmaceuticals Ltd. 3.49 -2.34
    GrossProfit Syngene International Ltd. 0.00 0.00 Aarey Drugs & Pharmaceuticals Ltd. 0.00 0.00
    ReportedPAT Syngene International Ltd. 148.20 16.50 Aarey Drugs & Pharmaceuticals Ltd. 1.56 0.57
    Equity Capital Syngene International Ltd. 402.90 402.90 Aarey Drugs & Pharmaceuticals Ltd. 28.45 28.45
    OPM Syngene International Ltd. 19.68 10.49 Aarey Drugs & Pharmaceuticals Ltd. 1.84 -2.42
    GPM Syngene International Ltd. 0.00 0.00 Aarey Drugs & Pharmaceuticals Ltd. 0.00 0.00
    NPM Syngene International Ltd. 15.43 0.00 Aarey Drugs & Pharmaceuticals Ltd. 0.82 0.59

    Annual Trends

    Syngene International Ltd. Aarey Drugs & Pharmaceuticals Ltd.
    Year Ends (Months) 202603(12) 202503(12) 202603(12) 202503(12)
    OperatingIncome Syngene International Ltd. 3423.80 3373.30 Aarey Drugs & Pharmaceuticals Ltd. 472.27 473.94
    OperatingProfit Syngene International Ltd. 814.60 917.60 Aarey Drugs & Pharmaceuticals Ltd. 7.17 2.90
    OtherRecurrInc Syngene International Ltd. 66.90 70.50 Aarey Drugs & Pharmaceuticals Ltd. 6.10 9.81
    AdjustedPBT Syngene International Ltd. 468.40 589.60 Aarey Drugs & Pharmaceuticals Ltd. 5.41 6.10
    ReportedPAT Syngene International Ltd. 304.90 468.00 Aarey Drugs & Pharmaceuticals Ltd. 3.97 4.02
    EquityDividend Syngene International Ltd. 0.00 0.00 Aarey Drugs & Pharmaceuticals Ltd. 0.00 0.00
    EquityCapital Syngene International Ltd. 402.90 402.50 Aarey Drugs & Pharmaceuticals Ltd. 28.45 28.45
    PreferenceCapital Syngene International Ltd. 0.00 0.00 Aarey Drugs & Pharmaceuticals Ltd. 0.00 0.00
    ResAndSurplus Syngene International Ltd. 4300.90 4236.40 Aarey Drugs & Pharmaceuticals Ltd. 121.97 107.51
    LoanFunds Syngene International Ltd. 0.00 102.50 Aarey Drugs & Pharmaceuticals Ltd. 49.96 34.86
    AL_CurrentLiabilities Syngene International Ltd. 1859.00 1665.50 Aarey Drugs & Pharmaceuticals Ltd. 96.86 117.26
    NetBlock Syngene International Ltd. 3028.20 2241.20 Aarey Drugs & Pharmaceuticals Ltd. 25.78 16.22
    Investments Syngene International Ltd. 1563.50 1468.00 Aarey Drugs & Pharmaceuticals Ltd. 2.12 2.12
    TotCurrentAssets Syngene International Ltd. 1971.10 1817.60 Aarey Drugs & Pharmaceuticals Ltd. 269.35 272.26

    Ratios

    Syngene International Ltd. Aarey Drugs & Pharmaceuticals Ltd.
    Year Ends (Months) 202603(12) 202503(12) 202603(12) 202503(12)
    OPM Syngene International Ltd. 23.79 27.20 Aarey Drugs & Pharmaceuticals Ltd. 1.51 0.61
    NPM Syngene International Ltd. 8.90 13.87 Aarey Drugs & Pharmaceuticals Ltd. 0.84 0.84
    Reported EPS Syngene International Ltd. 7.57 11.63 Aarey Drugs & Pharmaceuticals Ltd. 1.39 1.43
    Return on Networth Syngene International Ltd. 6.48 10.08 Aarey Drugs & Pharmaceuticals Ltd. 2.63 2.95
    Debt/ Equity Syngene International Ltd. 0.00 0.02 Aarey Drugs & Pharmaceuticals Ltd. 0.33 0.25
    Financial Charges Coverage Ratio Syngene International Ltd. 33.90 31.67 Aarey Drugs & Pharmaceuticals Ltd. 2.65 2.73
    Current Ratio Syngene International Ltd. 1.06 1.09 Aarey Drugs & Pharmaceuticals Ltd. 2.78 2.32
    Dividend per share Syngene International Ltd. 1.25 1.25 Aarey Drugs & Pharmaceuticals Ltd. 0.00 0.00

    Way2Wealth Brokers Private Limited - CIN U67120KA2000PTC027628 Stock Broking: SEBI Regn No.: INZ000178638 | Exchange Membership ID: NSE: 11502, BSE: 3117, MSEI:51000, MCX: 56730 Depository Participant: SEBI Regn No. IN-DP-472-2020 | CDSL ID: 12062900 & 12031500, NSDL ID: IN303077 | Research Analyst: SEBI Regn No. INH200008705 | PMS: SEBI Regn No.INP000000829 | Register with AMFI ARN: 77558 (Date of Initial registration - 8th Dec 2009, Date of expiry - 24th Jan 2027) | PFRDA: POP226012019

    Way2Wealth Commodities Private Limited - CIN U51229KA2006PTC039880 Stock Broking: SEBI Regn No.: INZ000049130 | Exchange Membership ID: NCDEX : 00908

    Copyrights @ 2014 © Way2Wealth Brokers Pvt. Ltd. All rights reserved

    Designed, developed and content provided by  Dion

    Procedure to file a complaint on SEBI SCORES: Register on SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances.